Giovanna Gallo

Pubblicazioni

Titolo Pubblicato in Anno
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication JOURNAL OF CLINICAL MEDICINE 2024
Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2024
New Insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
A Mobile App-based Approach in Cardiovascular Disease Prevention: A Prospective Randomized Study HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2024
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Hypertension and Heart Failure: From Pathophysiology to Treatment INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases JOURNAL OF HYPERTENSION 2024
Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2024
Update on obesity and cardiovascular risk: from pathophysiology to clinical management NUTRIENTS 2024
New insight in cardiorenal syndrome: from biomarkers to therapy INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure CELLULAR AND MOLECULAR LIFE SCIENCES 2023
Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction INTERNATIONAL JOURNAL OF CARDIOLOGY 2023
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension MOLECULAR MEDICINE 2023
Effects of two-month treatment with a mixture of natural activators of autophagy on oxidative stress and arterial stiffness in patients with essential hypertension: A pilot study NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
From cardiovascular system to brain, the potential protective role of mas receptors in COVID-19 infection EUROPEAN JOURNAL OF PHARMACOLOGY 2023
Hypertension, coronary artery disease and myocardial ischemic syndromes VASCULAR PHARMACOLOGY 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma